Intravenous ribavirin therapy in a neonate with disseminated adenovirus infection undergoing extracorporeal membrane oxygenation: Pharmacokinetics and clearance by hemofiltration

被引:28
作者
Aebi, C [1 ]
Headrick, CL [1 ]
McCracken, GH [1 ]
Lindsay, CA [1 ]
机构
[1] CHILDRENS MED CTR, DEPT PHARM, DALLAS, TX 75235 USA
基金
新加坡国家研究基金会;
关键词
D O I
10.1016/S0022-3476(97)70246-4
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Intravenously administered ribavirin (20 mg/kg per day) was given to a neonate with disseminated adenovirus infection requiring extracorporeal membrane oxygenation and hemofiltration, Plasma concentrations at steady state were 4.81 to 8.47 mu g/ml, hemofiltration sieving coefficient was 0.85, and hemofiltration clearance (0.046 L/kg per hour) was similar to the renal clearance reported with normal kidney function, Despite low plasma concentrations, results of viral cultures were negative within 48 hours of initiation of ribavirin therapy, suggesting that plasma concentrations may not adequately predict inhibition of adenovirus replication in vivo.
引用
收藏
页码:612 / 615
页数:4
相关论文
共 12 条
[1]  
ABZUG MJ, 1991, PEDIATRICS, V87, P890
[2]   SENSITIVE RADIOIMMUNOASSAY FOR THE BROAD-SPECTRUM ANTIVIRAL AGENT RIBAVIRIN [J].
AUSTIN, RK ;
TREFTS, PE ;
HINTZ, M ;
CONNOR, JD ;
KAGNOFF, MF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :696-701
[3]   SAFETY, TOLERANCE, AND PHARMACOKINETICS OF SYSTEMIC RIBAVIRIN IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
CONNOR, E ;
MORRISON, S ;
LANE, J ;
OLESKE, J ;
SONKE, RL ;
CONNOR, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (03) :532-539
[4]   SEVERE DIFFUSE ADENOVIRUS-7A PNEUMONIA IN A CHILD WITH COMBINED IMMUNODEFICIENCY - POSSIBLE THERAPEUTIC EFFECT OF HUMAN IMMUNE SERUM GLOBULIN CONTAINING SPECIFIC NEUTRALIZING ANTIBODY [J].
DAGAN, R ;
SCHWARTZ, RH ;
INSEL, RA ;
MENEGUS, MA .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1984, 3 (03) :246-251
[5]   PLASMA DISAPPEARANCE, URINE EXCRETION, AND TISSUE DISTRIBUTION OF RIBAVIRIN IN RATS AND RHESUS-MONKEYS [J].
FERRARA, EA ;
OISHI, JS ;
WANNEMACHER, RW ;
STEPHEN, EL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (06) :1042-1049
[6]   IMMUNOGLOBULIN ADMINISTRATION AND RIBAVIRIN THERAPY - EFFICACY IN RESPIRATORY SYNCYTIAL VIRUS-INFECTION OF THE COTTON RAT [J].
GRUBER, WC ;
WILSON, SZ ;
THROOP, BJ ;
WYDE, PR .
PEDIATRIC RESEARCH, 1987, 21 (03) :270-274
[7]  
HALL CB, 1993, PEDIATRICS, V92, P501
[8]   RIBAVIRIN DISPOSITION IN HIGH-RISK PATIENTS FOR ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
LASKIN, OL ;
LONGSTRETH, JA ;
HART, CC ;
SCAVUZZO, D ;
KALMAN, CM ;
CONNOR, JD ;
ROBERTS, RB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (05) :546-555
[9]  
Lindsay CA, 1996, PHARMACOTHERAPY, V16, P458
[10]  
MCCARTHY AJ, 1995, PEDIATR INFECT DIS J, V14, P1003